Salarius Pharmaceuticals Inc (SLRX)

[jaj-dan]

So it appears most of the chief executives have all filed form 4's over the past 30 days, acquiring additional shares. They obviously know something is about to pop! I think this past week's jump is just the beginning.

[stockmule]

I'm on board giving it a chance due to insider buying.

[jaj-dan]

Salarius Pharmaceuticals to Present During Virtual LD 500 Conference https://seekingalpha.com

[jaj-dan]

That was quick.

Salarius Announces Closing of $6.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option https://seekingalpha.com

[jaj-dan]

SLRX to expand clinical trials to additional sarcomas.

https://www.globenewswire.com/news-release/2020/07/29/2069783/0/en/Salarius-Pharmaceuticals-to-Expand-Clinical-Program-to-Target-Additional-Sarcomas-in-Ewing-Sarcoma-Phase-1-2-Clinical-Trial.html

[jaj-dan]

https://www.globenewswire.com/news-release/2020/07/28/2068628/0/en/Salarius-Pharmaceuticals-Announces-Move-to-New-Corporate-Offices-at-Texas-Medical-Center.html

[jaj-dan]

SLRX moves corporate office to Texas medical center and opens new laboratory to J&J’s JLAB!! Lots of changes happening here!

Salarius Pharmaceuticals Announces Move to New Corporate Offices at Texas Medical Center https://seekingalpha.com

[jaj-dan]

Salarius Pharmaceuticals Names Nadeem Mirza, M.D., M.P.H., as Senior Vice President Clinical Development https://seekingalpha.com

[axelvento]

TODAY :https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-agenda-and-public-participation-information-june-17-18-2020-meeting-pediatric-oncology#event-material


ALERT!

[jaj-dan]

https://www.benzinga.com/news/20/06/16261384/benchmark-initiates-coverage-on-salarius-pharmaceuticals-with-speculative-buy-rating-announces-price

[jaj-dan]

Chart is looking good now. Daily volume has double in the last 10 minutes.

[jaj-dan]

$1.65 is huge resistance mark for SLRX. Now broken with green hammer. Let’s see if we get bullish here now!

[swingingRichard]

* * * $SLRX Chart Analysis * * *

Meh . . .

[TheFinalCD]

1.25 off of 1.70 hi after halt resume

SLRX

[jaj-dan]

Salarius Pharmaceuticals to Present Trial in Progress Poster at ASCO20 Virtual Scientific Program https://seekingalpha.com

[CAZZZ]

big volume, slow but positive gains, I like it alot.

[jaj-dan]

Nice. Good for you.

[CAZZZ]

Big volume early

[CAZZZ]

in for $5k at 1.13, lets roll

[jaj-dan]

Nice $1.29 AH. This has to start hitting scanners.

[jaj-dan]

I have no idea. Only thing recent is that they didn’t lose as much money as expected on their quarterly. Which is what the merger and shake up was planned to do, tighten the reigns and set new management, etc. Plan is in motion I guess.

[CAZZZ]

woohooo runnnn forest !!!!!!!!

[CAZZZ]

Big finish, be nice to see a gap up tomorrow

[CAZZZ]

Wow nice ! The reason or movement today ??

[jaj-dan]

CNN Business Price target $3.80.

Recognia Reasearch Firm rates strong buy short and mid term.

Marketwatch.com has buy rating.


https://money.cnn.com/quote/forecast/forecast.html?symb=SLRX

[CAZZZ]

definitely some flipping happening here

[CAZZZ]

Down she goes, strange movement today

[CAZZZ]

showing good support at 1.14

[CAZZZ]

Holy roller coaster

[jaj-dan]

Time to average down. I just didn’t want to sink any more money here but it only makes sense.

[CAZZZ]

This could fly

[CAZZZ]

Have to bust 1.18

[CAZZZ]

Ouch, sorry, you might get a few bucks back here

[jaj-dan]

A giant turd. I’ve been holding since merger with FLKS and than it RS. My cost basis is friggin $17.44.

[CAZZZ]

Not in the spotlight yet and moving big

[fbsf32]

Looking good.

[CAZZZ]

No one but meee ???

[CAZZZ]

Anyone watching this ???

[ClayTrader]

* * $SLRX Video Chart 04-27-2020 * *

Link to Video - click here to watch the technical chart video

[KingT]

This can easily gallop back up to 1 plus

[Decarz]

Here are the recent Insiders Buying...........................,,.,
Lastest Insider Transactions Of Salarius Pharmaceuticals, Inc. ( SLRX )
Symbol Company Name Insider Name Title Date Transation Share Price Amount File Date
SLRX Salarius Pharmaceuticals, Inc. Rosenblum Mark J Exec VP Finance, CFO 2020-02-19 Buy 2,000 0.95 1,900 2020-02-20 16:07:57
SLRX Salarius Pharmaceuticals, Inc. Jordan Scott Chief Business Officer 2020-02-18 Buy 11,300 0.90 10,170 2020-02-18 16:48:00
SLRX Salarius Pharmaceuticals, Inc. Rosenblum Mark J Exec VP Finance, CFO 2020-02-13 Buy 5,000 0.86 4,295 2020-02-13 17:57:33
SLRX Salarius Pharmaceuticals, Inc. McVicar William K. Directior 2020-02-11 Buy 8,700 1.15 10,005 2020-02-12 21:36:32
SLRX Salarius Pharmaceuticals, Inc. Northrup Jonathan P Directior 2020-02-11 Buy 8,700 1.15 10,005 2020-02-12 21:34:42
SLRX Salarius Pharmaceuticals, Inc. Burleson Tess Directior 2020-02-11 Buy 4,350 1.15 5,003 2020-02-12 21:34:31
SLRX Salarius Pharmaceuticals, Inc. HANISH ARNOLD C Directior 2020-02-11 Buy 4,350 1.15 5,003 2020-02-12 21:33:56
SLRX Salarius Pharmaceuticals, Inc. McCreedy Bruce J Jr. Directior 2020-02-11 Buy 8,700 1.15 10,005 2020-02-12 21:33:35
SLRX Salarius Pharmaceuticals, Inc. Arthur David J. Chief Executive Officer 2020-02-11 Buy 2,175 1.15 2,501 2020-02-12 21:32:05
SLRX Salarius Pharmaceuticals, Inc. HANISH ARNOLD C Directior 2019-11-25 Buy 3,000 3.59 10,770 2020-02-12 21:27:59
SLRX Salarius Pharmaceuticals, Inc. HANISH ARNOLD C Directior 2019-11-25 Buy 3,000 3.59 10,770 2019-11-26 08:47:47

[Skidoonut]

Think that low? I'm not saying teens, .50 is a really good buy in my opinion but i think it'll go to .60s.

[420man]

See you in the teens... Tick Tock

[axelvento]

http://www.globenewswire.com/news-release/2019/12/17/1961523/0/en/Salarius-Pharmaceuticals-Hosting-Key-Opinion-Leader-Call-on-Epigenetics-The-Regulatory-System-That-Affects-Gene-Expression.html

[axelvento]

zero dilution$$$$$

This common stock purchase agreement with Aspire Capital provides Salarius with additional access to capital and financing flexibility allowing Salarius to further advance its lead drug candidate, Seclidemstat,” commented David Arthur, Chief Executive Officer of Salarius. “We believe our non-dilutive financial support from both CPRIT and the National Pediatric Cancer Foundation, now combined with funding from Aspire Capital, puts Salarius in a good financial position as we continue our work targeting the epigenetic causes of cancer.”

http://salariuspharma.com/2019/10/28/salarius-pharmaceuticals-and-aspire-capital-announce-a-10-9m-common-stock-purchase-agreement/

[ALERTS100%to10000%GAIN]

breaking 5.00 and loose

[ALERTS100%to10000%GAIN]

crazy buying pressure

[axelvento]

SUPER LOW FLOAT$

[TheFinalCD]

4.15


junki

[ALERTS100%to10000%GAIN]

L2 very thin ,could break crazy ,look at it